Performance of Red Tinted Contact Lenses on Colour Defects (CL)

December 1, 2022 updated by: National University of Malaysia

The Performance of Red Tinted Contact Lenses of Various Tones on Colour Deficient Subjects: A Pilot Study

This study aimed to relate and compare the performance of 4 types of red-tinted contact lenses (CL) with the Total Error Score (TES) from the Farnsworth-Munsell 100 Hue test on colour deficient subjects. Only 6 subject with colour vision defect was tested in this study.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Six congenital CVD subjects were recruited. After colour vision screening using Ishihara plate, the Farnsworth-Munsell 100 Hue test was carried out to determine the type and severity of colour vision deficiency. Four types of red-tinted CL (Type A, B, C and D) were used. The performance of each of these lenses was determined through the comparison of error scores in the Ishihara test before and after wearing tinted contact lens on only the non-dominant eye. Then, the transmittance of each tinted CL was determined using a spectrophotometer. All these lenses were fitted on the subjects in one day where the subjects were given a 30-minute break for each intervention.

Study Type

Interventional

Enrollment (Actual)

6

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kuala Lumpur, Malaysia, 50300
        • Optometry Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age range 18-40 years
  • all sex
  • color defect diagnosed with Ishihara Test
  • no contraindication in contact lens wear

Exclusion Criteria:

  • have ocular and systemic diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Device Feasibility
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: TES and performance assessment with Type A Red Tint Lens
6 subjects will be inserted with the Type A red Tint Lenses. Only the non dominant eye will be inserted. The comparison is made before and after wearing the CL.
to compare the performance of these lenses.
Other Names:
  • IGEL Red tint lens type1
  • IGEL Red tint lens type 2
  • OCULUS Red tint lens
  • MAXVUE Red tint lens
Active Comparator: TES and performance assessment with Type B Red Tint Lens
6 subjects will be inserted with the Type B red Tint Lenses. Only the non dominant eye will be inserted. The comparison is made before and after wearing the CL.
to compare the performance of these lenses.
Other Names:
  • IGEL Red tint lens type1
  • IGEL Red tint lens type 2
  • OCULUS Red tint lens
  • MAXVUE Red tint lens
Active Comparator: TES and performance assessment with Type C Red Tint Lens
6 subjects will be inserted with the Type C red Tint Lenses. Only the non dominant eye will be inserted. The comparison is made before and after wearing the CL.
to compare the performance of these lenses.
Other Names:
  • IGEL Red tint lens type1
  • IGEL Red tint lens type 2
  • OCULUS Red tint lens
  • MAXVUE Red tint lens
Active Comparator: TES and performance assessment with Type D Red Tint Lens
6 subjects will be inserted with the Type D red Tint Lenses. Only the non dominant eye will be inserted. The comparison is made before and after wearing the CL.
to compare the performance of these lenses.
Other Names:
  • IGEL Red tint lens type1
  • IGEL Red tint lens type 2
  • OCULUS Red tint lens
  • MAXVUE Red tint lens

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The lens which gives the best result in TES value
Time Frame: 30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed.
The highest TES value scored showed higher performance in colour vision. TES is an automated, generated value that calculates the number of tiles placed incorrectly and scales the value for uniform analysis. Average TES scores range from thirty to forty in series tests; while scores exceeding seventy can point to a marker for color blindness. Lower scores are intended to point to significantly increased color vision accuracy, as the TES score is directly correlated to the number of tiles incorrectly identified
30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed.
The lens which gives the best performance in ES value
Time Frame: 30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed
The highest score achieved using Ishihara Test indicates the best red tint lens. The current passing score is 12 correct of 14 red/green test plates (not including the demonstration plate). Research has shown that scores below twelve indicate color vision deficiency, and twelve or more correct indicate normal color vision, with 97% sensitivity and 100% specificity
30 minutes after lens adaptation. Lens is removed immediately after the assessment is completed

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Haliza Abdul Mutalib, PhD, UKM

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 20, 2020

Primary Completion (Actual)

April 30, 2021

Study Completion (Actual)

July 31, 2021

Study Registration Dates

First Submitted

November 21, 2022

First Submitted That Met QC Criteria

December 1, 2022

First Posted (Estimate)

December 8, 2022

Study Record Updates

Last Update Posted (Estimate)

December 8, 2022

Last Update Submitted That Met QC Criteria

December 1, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

only the executive summary of all data analysis published by journals will be made available. IPD will be shared only when requested.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Color Vision Defects

Clinical Trials on red tint contact lenses

Subscribe